The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target
Abstract A cluster of differentiation 36 (CD36), also known as fatty acid translocase, plays an important role in developing and progressing metabolic diseases. Soluble CD36 (sCD36), a circulating form of CD36, is identified in human plasma. Current studies have demonstrated that sCD36 is an early b...
Saved in:
Main Authors: | Yun Li (Author), Yaxi Chen (Author), Xiong Z. Ruan (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Periostin: A Potential Biomarker and Therapeutic Target in Pulmonary Diseases
by: Nafaa Alzobaidi, et al.
Published: (2022) -
The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases
by: Wei Tang, et al.
Published: (2022) -
Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females
by: Maïmouna Touré, et al.
Published: (2022) -
Human Skin Cancer, Potential Biomarkers and Therapeutic Targets
Published: (2016) -
LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases
by: Shi-Feng Huang, et al.
Published: (2021)